512 related articles for article (PubMed ID: 19469706)
1. Viremia in acute herpes zoster.
Satyaprakash AK; Tremaine AM; Stelter AA; Creed R; Ravanfar P; Mendoza N; Mehta SK; Rady PL; Pierson DL; Tyring SK
J Infect Dis; 2009 Jul; 200(1):26-32. PubMed ID: 19469706
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir treatment prevents varicella-zoster virus replication in PBMC during viremia.
Wolff MH; Schünemann S
New Microbiol; 1999 Oct; 22(4):309-14. PubMed ID: 10555200
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
[TBL] [Abstract][Full Text] [Related]
4. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA;
J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation.
Kalpoe JS; Kroes AC; Verkerk S; Claas EC; Barge RM; Beersma MF
Bone Marrow Transplant; 2006 Jul; 38(1):41-6. PubMed ID: 16715108
[TBL] [Abstract][Full Text] [Related]
6. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
7. Effect of acyclovir and prednisolone on the serological response in herpes zoster.
Bates CJ; Kudesia G; McKendrick MW
J Med Virol; 1996 Nov; 50(3):244-8. PubMed ID: 8923289
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy.
Kawaguchi K; Inamura H; Abe Y; Koshu H; Takashita E; Muraki Y; Matsuzaki Y; Nishimura H; Ishikawa H; Fukao A; Hongo S; Aoyagi M
Laryngoscope; 2007 Jan; 117(1):147-56. PubMed ID: 17202945
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT.
Klein A; Miller KB; Sprague K; DesJardin JA; Snydman DR
Bone Marrow Transplant; 2011 Feb; 46(2):294-9. PubMed ID: 20421867
[TBL] [Abstract][Full Text] [Related]
12. Valacyclovir for the treatment of genital herpes.
Brantley JS; Hicks L; Sra K; Tyring SK
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
[TBL] [Abstract][Full Text] [Related]
13. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
14. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD
Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
[TBL] [Abstract][Full Text] [Related]
15. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.
Lopez AS; Burnett-Hartman A; Nambiar R; Ritz L; Owens P; Loparev VN; Guris D; Schmid DS
J Infect Dis; 2008 Mar; 197(5):646-53. PubMed ID: 18260757
[TBL] [Abstract][Full Text] [Related]
16. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster.
Suzuki K; Yoshikawa T; Tomitaka A; Matsunaga K; Asano Y
J Infect Dis; 2004 Mar; 189(6):1009-12. PubMed ID: 14999603
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
[TBL] [Abstract][Full Text] [Related]
18. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
19. Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete.
Kido S; Sugita S; Horie S; Miyanaga M; Miyata K; Shimizu N; Morio T; Mochizuki M
Br J Ophthalmol; 2008 Apr; 92(4):505-8. PubMed ID: 18245272
[TBL] [Abstract][Full Text] [Related]
20. Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
Fukushima T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Masaki Y; Okazaki T; Nakajima H; Motoo Y; Umehara H
Anticancer Res; 2012 Dec; 32(12):5437-40. PubMed ID: 23225448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
